Skip to main content
. 2021 Jun 16;12:651926. doi: 10.3389/fphar.2021.651926

FIGURE 1.

FIGURE 1

The role of gut microbiota in cardiovascular disease and flavonoid metabolism. The GM produces TMA by ingesting choline (such as choline, phosphatidylcholine and l–carnitine) from food. TMA enters the liver through the hepatointestinal circulation, and forms TMAO through the oxidation of flavin monooxygenase, then enters the systemic circulation. Circulating TMAO levels increase, causing foam cells and platelets to accumulate, while affecting cholesterol transport, thereby promoting atheromatous plaque formation.